Cannabis UseNCT07813442
Activity-Based Intervention to Address Cannabis Use
A study testing Motivational and Behavioral Economics Informed Intervention in people with Cannabis Use, run by University of Michigan at 1 site in United States.
Trial summary
This study is being completed to test a method to promote patient-centered outcomes among people who use cannabis behaviors. Read more about this study
- Who is it for?
- Ages 18 to 70 years
- Conditions the study is for
- Cannabis Use
- What is being tested?
- Motivational and Behavioral Economics Informed Intervention
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 300 participants
- Where
- 1 siteUnited States
- Study dates
- Feb 2027to Sep 2030
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 70 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- current cannabis use disorder
- active cannabis use,
- camera/technology/phone access
- able to give informed consent.
Who cannot join
- inability to speak English
- conditions precluding informed consent, full participation, or understanding of interventions/assessments
- past 90-day cannabis use disorder/substance use disorder treatment
- current cancer treatment
- medical cannabis certification for current cancer, end-of-life care, or progressive debilitating disease
- active moderate/severe other substance use disorder(s) or injection drug use
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site
University of Michigan, Ann Arbor, Michigan 48109
Ann Arbor, Michigan, 48109
Braden Kilpatrick, 734-623-0713, bkilpatr@med.umich.edu
Erin Bonar, PhD
About this study
Official title: A Remote Behavioral Economics-Based Intervention for Cannabis Use Disorder: Bridging Gaps in Care
This study is being completed to test a method to promote patient-centered outcomes among people who use cannabis behaviors.
- Conditions
- Cannabis Use
- Being tested
- Motivational and Behavioral Economics Informed Intervention, Enhanced Usual Care
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Motivational and Behavioral Economics Informed InterventionBehavioural
6 session telemedicine-delivered intervention with coaching sessions and small incentives for activity engagement.
Enhanced Usual CareBehavioural
Brief psychoeducation and referral resources
| Study group | Role | What they receive |
|---|---|---|
| MI-BE | Experimental | Not described Receives: Behavioral: Motivational and Behavioral Economics Informed Intervention |
| EUC | Active comparator | Not described Receives: Behavioral: Enhanced Usual Care |
What is being measured
The primary outcome is the main question the study is designed to answer.
Cannabis use
Change in frequency of cannabis use measured by the Timeline Follow Back
Measured: 3-, 6-, 12-months
Secondary outcomes (3)
Cannabis use disorder symptoms
Change in cannabis use disorder symptoms measured by the Diagnostic \& Statistical Manual-5 checklist where higher scores indicate a worse outcome (0 min score, 11 max score)
Measured: 3-, 6-, 12-months
Depressive symptoms
Change in depression symptom severity as measured by Patient Health Questionnaire-where higher scores indicate a worse outcome (min score = 0, max score = 24)
Measured: 3-, 6-, 12-months
Anxiety symptoms
Change in anxiety symptom severity as measured by Generalized Anxiety Disorder-7 questionnaire where higher scores indicate a worse outcome (min score = 0, max score = 21)
Measured: 3-, 6-, 12-months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted10 Sep 2026
- Study startFeb 2027 (estimated)
- Primary completionSep 2030 (estimated)
- Study completionSep 2030 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Cannabis UseStudies of the same condition, open and under way.
- More trials run by University of MichiganThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Investigator, Outcomes assessor
- Enrolment
- 300 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Michigan
- Sponsor type
- University, hospital or other
- Collaborators
- National Institute on Drug Abuse (NIDA)
- Responsible party
- Principal investigator, Erin Bonar, University of Michigan
- Investigators
- Erin Bonar, PhD, Principal investigator, University of MichiganLara Coughlin, PhD, Principal investigator, University of Michigan
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07813442
- Sponsor's protocol ID
- HUM00291757
- Other IDs
- R01DA062399
- Status last verified
- Sep 2026
- First submitted
- 4 Sep 2026
- Last updated
- 14 Sep 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 14 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Remote Behavioral Economics-Based Intervention for Cannabis Use Disorder: Bridging Gaps in Care
- ClinicalTrials.gov ID
- NCT07813442
- Acronym / sponsor ID
- HUM00291757
- Conditions
- Cannabis Use
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 300 participants (estimated)
- Lead sponsor
- University of MichiganUniversity, hospital or other
- Collaborators
- National Institute on Drug Abuse (NIDA)
- Study start
- Feb 2027 (estimated)
- Primary completion
- Sep 2030 (estimated)
- Study completion
- Sep 2030 (estimated)
- First posted
- 10 Sep 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study is being completed to test a method to promote patient-centered outcomes among people who use cannabis behaviors.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (investigator, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| MI-BE | Experimental | Behavioral: Motivational and Behavioral Economics Informed Intervention |
| EUC | Active comparator | Behavioral: Enhanced Usual Care |
Who may qualify
- Ages
- 18 to 70 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- current cannabis use disorder
- active cannabis use,
- camera/technology/phone access
- able to give informed consent.
Key exclusion criteria (6 listed)
- inability to speak English
- conditions precluding informed consent, full participation, or understanding of interventions/assessments
- past 90-day cannabis use disorder/substance use disorder treatment
- current cancer treatment
- medical cannabis certification for current cancer, end-of-life care, or progressive debilitating disease
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Motivational and Behavioral Economics Informed Intervention6 session telemedicine-delivered intervention with coaching sessions and small incentives for activity engagement. | Behavioural | MI-BE |
| Enhanced Usual CareBrief psychoeducation and referral resources | Behavioural | EUC |
Primary outcome
Cannabis use
Time frame: 3-, 6-, 12-months
Change in frequency of cannabis use measured by the Timeline Follow Back
3 secondary outcomes
Cannabis use disorder symptoms
Time frame: 3-, 6-, 12-months
Depressive symptoms
Time frame: 3-, 6-, 12-months
Anxiety symptoms
Time frame: 3-, 6-, 12-months
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 Sep 2026.
- Individual participant dataSharing planned: No
Related trials for Cannabis Use
Active, not recruitingObservational study
Cannabis Use and Outcomes in Black and White Patients With Cancer
Cancer
Recruiting
MATAspire: Mental Health Awareness Tailored App for Substance Prevention and Integrated Resilience Education
Alcohol Use, Cannabis Use
RecruitingObservational study
A Study in Patients Reporting Cannabis Use Followed With an Application-Based Cannabis Journal
Cancer
RecruitingObservational study
Study of an Oral Fluid Testing Approach
Cannabis Use, Cannabis Intoxication
Not yet recruitingEarly Phase 1
Research Investigating Drug Effects-2 (RiDE-2)
Cannabis Use, Substance Use Disorder (SUD)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Erin Bonar, PhD principal investigator
University of Michigan
Lara Coughlin, PhD principal investigator
University of Michigan
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Motivational and Behavioral Economics Informed Intervention in people with Cannabis Use, run by University of Michigan at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 14 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Braden Kilpatrick ((734) 623-0713, bkilpatr@med.umich.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Cannabis use (time frame: 3-, 6-, 12-months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Sep 2026.